Cargando…

Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture

BACKGROUND: Adoptive transfer of minor histocompatibility antigen (MiHA)-specific T cells is a promising therapy for patients with hematological cancers. However, the efficacy of the transferred cells is hampered by the acquisition of terminal effector differentiation and exhaustion features during...

Descripción completa

Detalles Bibliográficos
Autores principales: Janelle, Valérie, Carli, Cédric, Taillefer, Julie, Orio, Julie, Delisle, Jean-Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413989/
https://www.ncbi.nlm.nih.gov/pubmed/25925868
http://dx.doi.org/10.1186/s12967-015-0495-z
_version_ 1782368867053469696
author Janelle, Valérie
Carli, Cédric
Taillefer, Julie
Orio, Julie
Delisle, Jean-Sébastien
author_facet Janelle, Valérie
Carli, Cédric
Taillefer, Julie
Orio, Julie
Delisle, Jean-Sébastien
author_sort Janelle, Valérie
collection PubMed
description BACKGROUND: Adoptive transfer of minor histocompatibility antigen (MiHA)-specific T cells is a promising therapy for patients with hematological cancers. However, the efficacy of the transferred cells is hampered by the acquisition of terminal effector differentiation and exhaustion features during expansion in vitro thus preventing their function and persistence in vivo. Yet, the factors that induce T-cell differentiation and functional impairment in culture remain poorly defined and are likely to vary depending on the method used for expansion. METHODS: Using the clinically relevant HLA-A0201-restricted MiHA HA-1 as well as reagents and procedures that are readily transferable to a clinical environment, we designed a novel culture protocol and defined how exhaustion features appeared in function of time. The optimal time points for the expansion of “fit” MiHA-specific T cells were delineated using phenotypic and functional assessments including KLRG-1 and PD-1 surface markers as well as Ki67 staining and cytokine secretion assays. RESULTS: Following a priming phase, an enrichment step and a rapid expansion stage, our method generates MiHA-specific T-cell lines. Evidence of phenotypic and functional dysfunction appear in function of culture duration, but display different characteristics following the extension of the priming or rapid expansion phases. While repeated antigen exposure during the priming phase induced the decline of the antigen-specific population and the expression of PD-1 and KLRG-1 on antigen-specific CD8(+) T cells, the prolongation of an antigen-free expansion phase induced proliferation arrest and the relative loss of antigen-specific cells without impairing polyfunctional cytokine secretion or inducing PD-1 and KLRG-1 expression. A similar pattern was also observed after stimulating a virus-specific memory repertoire, except for the more rapid acquisition of exhaustion features upon repeated antigen exposure. CONCLUSION: Our results offer novel insights on the impact of culture duration on the acquisition of T-cell exhaustion features. Using a new clinical-compliant protocol, we define critical parameters to monitor in order to optimally differentiate and expand MiHA-specific T cells in culture prior to adoptive transfer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0495-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4413989
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44139892015-04-30 Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture Janelle, Valérie Carli, Cédric Taillefer, Julie Orio, Julie Delisle, Jean-Sébastien J Transl Med Research BACKGROUND: Adoptive transfer of minor histocompatibility antigen (MiHA)-specific T cells is a promising therapy for patients with hematological cancers. However, the efficacy of the transferred cells is hampered by the acquisition of terminal effector differentiation and exhaustion features during expansion in vitro thus preventing their function and persistence in vivo. Yet, the factors that induce T-cell differentiation and functional impairment in culture remain poorly defined and are likely to vary depending on the method used for expansion. METHODS: Using the clinically relevant HLA-A0201-restricted MiHA HA-1 as well as reagents and procedures that are readily transferable to a clinical environment, we designed a novel culture protocol and defined how exhaustion features appeared in function of time. The optimal time points for the expansion of “fit” MiHA-specific T cells were delineated using phenotypic and functional assessments including KLRG-1 and PD-1 surface markers as well as Ki67 staining and cytokine secretion assays. RESULTS: Following a priming phase, an enrichment step and a rapid expansion stage, our method generates MiHA-specific T-cell lines. Evidence of phenotypic and functional dysfunction appear in function of culture duration, but display different characteristics following the extension of the priming or rapid expansion phases. While repeated antigen exposure during the priming phase induced the decline of the antigen-specific population and the expression of PD-1 and KLRG-1 on antigen-specific CD8(+) T cells, the prolongation of an antigen-free expansion phase induced proliferation arrest and the relative loss of antigen-specific cells without impairing polyfunctional cytokine secretion or inducing PD-1 and KLRG-1 expression. A similar pattern was also observed after stimulating a virus-specific memory repertoire, except for the more rapid acquisition of exhaustion features upon repeated antigen exposure. CONCLUSION: Our results offer novel insights on the impact of culture duration on the acquisition of T-cell exhaustion features. Using a new clinical-compliant protocol, we define critical parameters to monitor in order to optimally differentiate and expand MiHA-specific T cells in culture prior to adoptive transfer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0495-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-19 /pmc/articles/PMC4413989/ /pubmed/25925868 http://dx.doi.org/10.1186/s12967-015-0495-z Text en © Janelle et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Janelle, Valérie
Carli, Cédric
Taillefer, Julie
Orio, Julie
Delisle, Jean-Sébastien
Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture
title Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture
title_full Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture
title_fullStr Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture
title_full_unstemmed Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture
title_short Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture
title_sort defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific t cells in culture
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413989/
https://www.ncbi.nlm.nih.gov/pubmed/25925868
http://dx.doi.org/10.1186/s12967-015-0495-z
work_keys_str_mv AT janellevalerie definingnovelparametersfortheoptimalprimingandexpansionofminorhistocompatibilityantigenspecifictcellsinculture
AT carlicedric definingnovelparametersfortheoptimalprimingandexpansionofminorhistocompatibilityantigenspecifictcellsinculture
AT tailleferjulie definingnovelparametersfortheoptimalprimingandexpansionofminorhistocompatibilityantigenspecifictcellsinculture
AT oriojulie definingnovelparametersfortheoptimalprimingandexpansionofminorhistocompatibilityantigenspecifictcellsinculture
AT delislejeansebastien definingnovelparametersfortheoptimalprimingandexpansionofminorhistocompatibilityantigenspecifictcellsinculture